Feb. 25 at 10:01 PM
$LMAT Q4 '25 Earnings Results & Recap
• Reported GAAP EPS of
$0.69 up 38.00% YoY
• Reported revenue of
$64.45M up 15.68% YoY
• Lemaitre Vascular projects full year 2026 sales between
$276MM and
$284MM, representing a 12% increase at the midpoint, and adjusted operating income of
$77.8mm, up 21%. Diluted EPS is guided to
$2.81-
$3.01.
